CAR- T and mobile gene therapies are actually too costly

.Nature Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production and innovation transfer can easily deliver cell genetics treatments at a budget-friendly price to patients all over the world.